11.05.2021 • NewsCroda

Croda Reviews PTIC businesses

Croda International has announced it is undertaking a strategic review of its Performance Technologies and Industrial Chemicals (PTIC) businesses. The primary aim, said the UK specialty chemicals company, will be to establish what type of ownership structure best serves the businesses going forward and create a stronger platform for its future growth.

The review expected to conclude by the end of 2021 is consistent with Croda’s prioritization of investments in faster-growth life science and consumer markets, which now represent over 80% of the group’s profitability, the company said. Its focus will be on the businesses and activities within PTIC that do not directly support the consumer care and life sciences sectors and will consider whether their full potential can be achieved under Croda, as a standalone business, or through a full or partial divestment.

PTIC’s manufacturing assets include facilities in the UK, The Netherlands, and China. The business focuses on fast-growth markets in the circular plastic economy, electric vehicles and other renewable technologies, supporting the division’s leading market positions in automotive, polymer and food packaging applications.

Author: Elaine Burridge, Freelance Journalist

Croda is undertaking a strategic review of its Performance Technologies and...
Croda is undertaking a strategic review of its Performance Technologies and Industrial Chemicals businesses. The review, expected to conclude by end 2021, will consider whether the businesses will do best under Croda, as a standalone company, or via a full or partial divestment. (c) Croda

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.